Who Brian Poteet Actually Is

The VitalRads origin story — as Poteet and the company have long told it — positions him as a visionary who built something from scratch. The record is more complicated, and understanding it matters because that independence narrative is the foundation on which clinics still trust the VitalRads brand today.

Poteet is a credentialed veterinary radiologist with dual board certifications (DACVR, DABSNM). He spent years as Director of Radiology at Gulf Coast Veterinary Specialists in Houston and held a faculty appointment at Texas A&M. He was a legitimate clinical expert. He was not the architect of veterinary teleradiology.

PetRays was founded in late 2006 by executives from human teleradiology — people who had built actual infrastructure for transmitting full DICOM at scale and transplanted it into veterinary medicine. Poteet was one of the founding radiologists they brought in for clinical credentialing. He did not design the system, fund it, or build the workflows. He lent his credentials to a platform that others had constructed. Shortly after launch he departed — returning to his day job at Gulf Coast and Texas A&M. What he had done was ride the PetRays train long enough to see exactly how a properly run veterinary teleradiology company worked. In 2010 he applied what he had observed and founded VitalRads. For a full account of PetRays and the broader history of the industry Poteet observed, see From Film to Fiber: A History of DICOM and the Rise of Veterinary Teleradiology.

That is not unusual in business. But it is a different story from the one VitalRads has marketed for fifteen years. And the founding year itself was legally turbulent in ways that have never appeared in any trade press coverage of the company.

The Founding Year: Two Lawsuits Nobody Reported

Poteet submitted his resignation from Texas Gulf Coast Veterinary Specialists (GCVS) — where he held a 12.9286% equity stake — on January 7, 2010. The company filed suit against him barely a month later. The case, filed February 8, 2010 in the 334th Judicial District of Harris County, Texas (Cause No. 2010-08060), named Poteet and alleged that during his 90-day notice period he had actively diverted clients to his new operation while still collecting his GCVS salary. The petition documented that 15 named client practices had collectively submitted 793 procedures to GCVS in the four months before Poteet's resignation — and abruptly stopped sending work after he gave notice. The causes of action included the Texas Theft Liability Act, misappropriation of trade secrets, breach of contract, and tortious interference.

Poteet's answer told a different story: that clients had contacted him voluntarily, that GCVS's February 9 termination for cause was pretextual — designed to deny him his 90-day compensation and force a below-value buyout of his ownership stake — and that GCVS partners had allegedly impersonated him to his cell carrier to obtain his phone records. He counterclaimed for breach of contract and minority shareholder oppression. The case settled April 23, 2010. All claims dismissed with prejudice. No findings of fact against either party. Each side bore its own costs.

VitalRads PLLC was formally incorporated by the Texas Secretary of State on April 22, 2010 — one day before that settlement was signed.

The second case is more revealing. PetRays, LP — along with PetRays Management GP, LLC and PetRays Veterinary Radiology Consultants, P.A. — filed suit in Montgomery County District Court in August 2010 (Cause No. 2010-08-09408, 359th Judicial District). The defendants were Brian Poteet and Vitalrads, PLLC — meaning VitalRads the company was named in civil litigation before most of the industry had heard of it.

The legal foundation was a General Release Agreement that Poteet had signed with PetRays effective December 31, 2008 — more than a year before his GCVS resignation. That agreement named specific clients he was barred from soliciting, including SonoPet, Marita Slatner, SonoSite, and Luiz Bolfer, and prohibited him from hiring PetRays employees. The petition alleged he had violated it by contacting six named client practices and by hiring a PetRays cardiologist to work at VitalRads.

More pointedly, the petition attached the GCVS lawsuit as an exhibit and argued a pattern across both disputes: the same practices that appeared in GCVS's client loss list were PetRays clients that Poteet had brought to Gulf Coast in the first place and was now, through VitalRads, taking a third time. Poteet's amended answer, filed through Porter & Hedges LLP, included a defense that doubles as a useful corporate timestamp: "Defendant Vitalrads, PLLC did not exist at the time of the release so it could not be engaged in fraud" — confirming that VitalRads was formed after the December 2008 Release was signed.

That case also settled. An Agreed Final Take Nothing Judgment was entered January 10, 2011. All parties took nothing. Consideration was paid. Dismissed with prejudice. No findings of fact against either party.

Neither case established wrongdoing. Both cases settle without adjudication on the merits, and this publication reports them as documented legal proceedings, not proven misconduct. What they establish is context: VitalRads launched out of a founding year in which its principal had already separated from two prior industry relationships under legal dispute, both settlements required payment of consideration, and the company itself was named as a defendant in civil litigation while it was still in its first months of existence. The "founded by Radiologists for Radiologists" story omits all of this.

The Trademark That Changes Everything: March 2018

For its first several years VitalRads operated as what it appeared to be: a small, radiologist-run practice in Cypress, Texas, building a clinical reputation and an ACVR-approved residency program. The public record, through at least 2016, is consistent with genuine independent operation.

What the trademark record shows is something different.

On October 9, 2015, VitalRads PLLC filed a trademark application with the United States Patent and Trademark Office for the word mark VITALRADS, covering veterinary radiology services (International Class 044). The mark was registered June 28, 2016, as Registration No. 4987362.

The mark did not remain with VitalRads PLLC. According to a Trademark Assignment recorded at the USPTO on September 16, 2019 (Reel 006755, Frame 0730), VitalRads PLLC transferred the VITALRADS mark — along with all associated goodwill — to Pathway Vet Alliance LLC. The assignment was executed effective March 6, 2018, and was signed by Brian Poteet as President of Vital Rads PLLC.

Pathway Vet Alliance was, by March 2018, already a private equity–backed veterinary consolidator. Morgan Stanley Capital Partners had acquired it in 2016. When TSG Consumer Partners acquired a majority stake from MSCP in April 2020 at an enterprise valuation estimated above $2 billion, the VITALRADS trademark transferred with the portfolio. When Pathway rebranded as Thrive Pet Healthcare in November 2021, VitalRads' brand had been private equity property for more than three years.

No press release accompanied the March 2018 transfer. No announcement was made to VitalRads client practices. No disclosure appeared in any public filing. VitalRads' own marketing continued to describe the company as "founded by Radiologists for Radiologists." The independence story was still being actively told. The federal trademark record said something else.

Texas corporate law adds a layer of legal complexity. A professional LLC providing veterinary services can only be owned by licensed veterinarians under Texas Occupations Code Chapter 301. A private equity entity like Pathway cannot hold equity in Vitalrads, PLLC. This means the trademark assignment is best understood as what corporate acquirers do when they cannot take the entity itself: they take the brand, the goodwill, and the name, and control the economics through a management services or licensing agreement. The operating PLLC, with Poteet as its sole licensed veterinarian-owner, continues as the professional shell through which services are delivered. The consolidator owns everything around it.

The 2024 Texas Franchise Tax Public Information Report for Vitalrads, PLLC, filed May 13, 2024, is consistent with this interpretation. Brian A. Poteet is listed as sole officer (President) and registered agent. Section C — which requires disclosure of any parent entity owning 10% or more — is blank. No parent is disclosed. The operating PLLC appears to remain in Poteet's name as the licensed professional entity, while the brand and the economics flow to Thrive through the trademark assignment and whatever management services or licensing agreement governs the relationship. Whether that agreement's terms have been disclosed to any regulatory body is not established by the public record.

The Thrive Financial Reality: What's Behind the Brand

Whatever the clinical quality of VitalRads' reads, the corporate entity that owns its brand is operating from a position of significant financial distress — a fact that carries direct implications for the continuity of service, the residency program, and the stability of the Zoetis integration built around it.

By mid-2024, S&P Global Ratings had downgraded Thrive Pet Healthcare to CCC+ — a designation that characterizes a capital structure as "likely unsustainable." S&P projected cash deficits of $80 to $90 million through the year. Moody's Investors Service revised its outlook to negative, citing potential default risk. The company's $1.55 billion first-lien term loan was trading in the high seventies — distressed territory. Thrive had gone through three CEOs in five years. Q3 2024 adjusted EBITDA came in 18% below the prior year and 38% below internal budget. Revenue was flat at $316 million for the quarter — 7% below plan.

On March 31, 2025, Thrive completed a liability management transaction involving more than $350 million in new liquidity and an extension of maturities on all existing debt instruments. The transaction required Evercore as Thrive's financial advisor, Ropes & Gray as Thrive's legal counsel, and Akin Gump as counsel to the lender group. Ropes & Gray's own deal announcement confirmed the scale: more than $1.7 billion in existing debt obligations extended. TSG Consumer Partners, the equity sponsor, supported the transaction. The underlying dynamics that produced the distress — difficulty recruiting veterinarians, fee compression, acquisition multiples that proved unsustainable — were not resolved by the extension. The debt was moved; the business problem persists.

VitalRads, operating as a Thrive subsidiary, is an asset on that balance sheet. Its clinical operations, its ACVR-approved residency program, its PACS infrastructure, and its referral relationships are all contingent on Thrive's financial survival. The VITALRADS trademark is encumbered by a Superpriority Trademark Security Agreement in favor of Wilmington Trust as Collateral Agent — the most senior layer in a lien chain that also includes security interests in favor of Jefferies Finance LLC and Ares Capital Corporation. In a formal restructuring or sale process, the VitalRads brand is collateral. The clinics and residents who depend on the platform's continuity have no voice in that process.

The VGP Conflict: A Corporate-Operated Organization That Presents Itself as an Independent Resource

This is the part of the VitalRads story that has been hiding in plain sight — and it is, structurally, the most dishonest element of the entire arrangement.

Veterinary Growth Partners (VGP) markets itself to independent veterinary practices as a membership organization: join, pay your membership fee, and receive access to group purchasing discounts on equipment, medical supplies, reference lab services, and pharmaceuticals, plus practice management coaching, benchmarking tools, and educational programs. VGP serves more than 7,300 member practices across the United States. Its pitch is independence and advocacy — a professional community working on behalf of the clinics that belong to it.

VGP is operated by Thrive Pet Healthcare.

This is confirmed, not alleged. dvm360 reported in March 2026 that VGP is "a value-added management services organization operated by Thrive Pet Healthcare." VGP was founded in 2013 by Jasen Trautwein, DVM, and Robert Sigman — prior to Thrive's ownership — but it is currently a Thrive-operated organization. The VGP website does not disclose this relationship in its consumer-facing materials. An independent practice owner visiting vgpvet.com to sign up for member benefits, or attending a VGP educational event, has no reason to know that the organization providing them "savings programs" is controlled by the country's fourth-largest veterinary clinic chain, which also owns the teleradiology company listed as a preferred vendor in their member portal.

On the VGP partner page, VitalRads appears as a listed partner. Member practices are directed to a "Partner Benefits Summary" for VitalRads — with the specific pricing visible only after logging in. The public description is standard VitalRads marketing copy. There is no disclosure that VitalRads and VGP share a corporate parent. There is no disclosure that the "discount" a VGP member receives on VitalRads is a price set by Thrive on a service owned by Thrive, distributed through a membership organization operated by Thrive, to practices that do not know any of this is happening.

The architecture is closed and self-referential. A practice joins VGP believing it is gaining access to independent purchasing leverage. It encounters VitalRads as a preferred partner with member pricing. It routes imaging cases to VitalRads. Revenue flows from the practice to VitalRads and up to Thrive. Thrive also operates VGP and receives the member fees the practice paid to join. The "independent advocate" and the service being recommended are the same corporate entity, at two different points of the same transaction.

This is not a technical disclosure gap. An independent practice owner who joined VGP to gain access to unbiased vendor recommendations has been steered to a corporate-owned service through a corporate-operated channel presenting itself as an independent advocate. In states with strong anti-kickback or fee-splitting provisions — and California, Texas, Florida, and New York are all on that list — the undisclosed financial benefit flowing from VGP members to VitalRads through a Thrive-controlled membership structure warrants serious regulatory scrutiny. The enforcement tools that exist to address exactly this kind of conduct are documented in detail in When the Right Enforcer Acts: The Federal Prosecution of U.S. Compounding and What It Means for Veterinary Teleradiology — a case in which federal prosecutors successfully pursued a six-year veterinary kickback scheme even without the primary federal anti-kickback statute applying, using the same state-law tools available to every attorney general in the country.

The competitive dimension compounds the problem. VGP's partner list also includes Zoetis — the same company that integrated VitalRads into its ZoetisDx portal. A practice that joins VGP for lab discounts, encounters Zoetis as a featured partner, and connects its practice management to ZoetisDx has been walked, step by step, through a referral funnel in which every gate is Thrive — without being told that any of those gates exist, let alone that they all connect to the same owner.

The Zoetis Integration: The Third Laboratory Giant Closes the Circle

On August 25, 2025, Zoetis Inc. — the world's largest animal health company by revenue at $9.3 billion — announced a partnership with VitalRads to embed teleradiology into its ZoetisDx Virtual Laboratory portal. The announcement was brief and corporate. Its structural significance was not.

The mechanics are documented in Zoetis's own public materials. Veterinary clinics that are Zoetis diagnostic customers log into ZoetisDx to access laboratory results, point-of-care analyzer data, and specialist consultation services. VitalRads teleradiology is now a native feature of that portal — accessible with the same credentials and within the same interface. A clinic staff member who has reviewed bloodwork through ZoetisDx can submit an imaging study to VitalRads without leaving the platform, without a separate login, and without any additional configuration. The Zoetis teleradiology information sheet summarizes it directly: "Access VitalRADS teleradiology services in your ZoetisDx portal. No contracts or set-up fees required."

Zoetis President for Global Diagnostics Abhay Nayak described VitalRads in the announcement as "our VitalRADS service" — not a third-party partner but a branded feature of the Zoetis diagnostic offering. The phrase is revealing. From Zoetis's perspective, VitalRads is an extension of its own platform. From the clinic's perspective, submitting a case to VitalRads through ZoetisDx feels like using a Zoetis product. The corporate chain that connects Zoetis (pharmaceutical giant, no ownership stake in VitalRads) to Thrive (PE-backed hospital chain, trademark and brand owner) to VitalRads PLLC (licensed Texas entity, Poteet nominally at the helm) is invisible at the interface level.

The Zoetis partnership also carries a specific disclosure problem. The Zoetis teleradiology page states that "all teleradiography cases are reviewed and finalized by board-certified specialists." VitalRads operates an ACVR-approved residency program, meaning residents — not yet board-certified diplomates — are actively engaged in reading cases. The question of whether residents perform primary reads that a supervising DACVR "finalizes" satisfies the Zoetis representation is an open one. If it does not, Zoetis has made a materially false representation to its clinic customers — a representation attributable to Zoetis directly, not merely to VitalRads. For a detailed comparison of how IDEXX structures its own service representations and contract disclaimers, see The IDEXX Ecosystem: How a Loyalty Program, a Liability Disclaimer, and a Perpetual Image License Work Together.

The Full Stack: How It Compares to IDEXX and Mars

The VitalRads / Thrive / Zoetis architecture is the third distinct model of vertical integration in veterinary teleradiology. Mapping it against the IDEXX and Mars models shows both what it has replicated and where it falls short. For a full analysis of how IDEXX assembled its stack, see The Stack: How IDEXX Built a Vertical Monopoly Over Veterinary Imaging. For the Mars/Antech model, see The Mars Empire: How One Candy Company Came to Own Your Pet's Exam, Bloodwork, and X-Ray.

Stack Layer	IDEXX	Mars / Antech	Zoetis / Thrive / VitalRads
Imaging reading service	IDEXX Teleradiology (in-house)	Antech Imaging Services (in-house)	VitalRads (Thrive subsidiary)
PACS / image archive	IDEXX Web PACS (proprietary)	SmartPACS (Sound Technologies)	VitalPACS (VitalRads proprietary)
Diagnostic portal	VetConnect PLUS	Antech portal / SmartPACS cloud	ZoetisDx.com (Zoetis-controlled)
In-clinic instruments	Catalyst, ProCyte, SediVue	Antech / Heska instruments	Vetscan series (Zoetis)
AI diagnostics	IDEXX AI / DecisionIQ	Limited	Vetscan Imagyst (Zoetis)
Reference laboratory	IDEXX Reference Laboratories	Antech Diagnostics	Not present — structural gap
Direct clinic ownership	None	Banfield, VCA, BluePearl (~2,000 US locations)	360+ hospitals (Thrive / TSG)
MSO / affiliated network	None	None (direct ownership instead)	VGP — 7,300+ practices (Thrive-operated, undisclosed)
Residency pipeline	Academic return-of-service (UF)	Internal / Cornell / UC Davis	ACVR-approved program at VitalRads
Financial sponsor	Public company (NASDAQ: IDXX)	Mars Inc. (~$50B revenue, private)	TSG Consumer Partners (PE) + Zoetis (NYSE: ZTS, $9.3B). Thrive rated CCC+.

The gap that matters most in this comparison is reference laboratory access. IDEXX's loyalty program works because lab samples and imaging referrals flow through the same billing relationship — practices using IDEXX for bloodwork receive points redeemable against their IDEXX Teleradiology bill. Antech operates the same model. Zoetis has no veterinary reference laboratory in the companion animal market. Its diagnostics revenue is built on consumables and instruments, not per-test reference fees. The Zoetis / Thrive / VitalRads stack cannot replicate the specific lab-to-imaging lock-in that makes the IDEXX and Antech models so durable.

What it can replicate — and has explicitly built — is the portal integration model: a single workflow environment in which the referring veterinarian's instrument data, diagnostic results, and imaging submissions flow through the same login. And through VGP, it has a distribution channel into 7,300 practices that IDEXX and Mars do not possess in the same form — a management services organization reaching independent clinics that have not been acquired, presenting itself as their advocate while feeding their referral volume to Thrive's balance sheet.

The Anticompetitive Ecosystem: How the Thrive Network Eliminates Meaningful Choice for Clinics — and the Animals They Treat

The competitive harm in the VitalRads / Thrive / Zoetis structure is not theoretical, and it is not limited to the antitrust frameworks that apply to IDEXX and Antech. It is a concrete, operational reality experienced by two distinct groups of veterinary practices — one that cannot choose at all, and one that has been maneuvered into a position where choice requires significant effort to exercise. In both cases, the animal patients and their owners bear the cost.

To understand why this matters, start with how the market is supposed to work. A veterinary clinic choosing a teleradiology provider in a genuinely competitive environment evaluates three things: the quality of the diagnostic report, the speed and reliability of turnaround, and the price per study. Those are measurable, comparable, and clinically meaningful factors. Independent board-certified veterinary radiologists — at Golden Hour, PetRad, Vets Choice Radiology, Vetology, and dozens of individual practices — compete directly on all three. The market rewards quality and efficiency and penalizes poor reports and slow turnarounds. That is how diagnostic markets are supposed to function. That is how referral decisions benefit patients.

The Thrive ecosystem has been structured in a way that short-circuits that process at two separate levels simultaneously.

Channel One: The Captive Clinics

Thrive Pet Healthcare directly owns or operates approximately 380 veterinary hospital locations across the United States. In those clinics, the teleradiology provider is not selected by the clinic veterinarian based on quality, price, or turnaround performance. It is VitalRads, because VitalRads is owned by the same corporate parent as the clinic. The referring veterinarian has no meaningful authority to deviate from that arrangement. The clinic owner — if the practice was acquired from an independent veterinarian who retained a partial ownership stake, as is common in Thrive's roll-up model — may not have been told that the teleradiology service is a Thrive subsidiary before the acquisition closed.

The competitive harm to independent teleradiology providers is direct and quantifiable. At the industry's current pricing range of $75 to $125 per routine radiograph study for board-certified reads from competitive independent providers, and assuming a conservative average of just three imaging studies per Thrive clinic per day across 380 locations, the captive volume approaches approximately 415,000 studies per year. That is 415,000 individual transactions per year — each representing a case where a referring veterinarian was prevented from selecting the best available reader at the best available price — flowing exclusively to a corporate-owned in-house service.

Independent teleradiology providers cannot access those cases. Not because their reads are inferior. Not because their prices are higher. But because the corporate owner of both the clinic and the reading service has eliminated the competitive decision entirely. Golden Hour, PetRad, Vets Choice Radiology, and every other independent board-certified service in the country have been foreclosed from roughly 380 locations' worth of volume regardless of how good they are.

Channel Two: The VGP Soft Capture — 7,300 Practices Who Think They Have a Choice

The second channel is more insidious precisely because it does not look like compulsion. Veterinary Growth Partners markets itself to independent practices — those that have not been acquired by Thrive, that still believe they are choosing their own vendors — as an advocacy organization offering negotiated group pricing and management resources. As of early 2026, VGP serves more than 7,300 member practices across the United States.

VGP is operated by Thrive Pet Healthcare. This fact does not appear in VGP's consumer-facing marketing. The dvm360 confirmation that VGP is "a value-added management services organization operated by Thrive Pet Healthcare" is the only public documentation of this relationship identified by this publication, buried in a trade press item about a separate partnership announcement. A practice owner visiting vgpvet.com to evaluate membership, or attending a VGP educational event, would have no reason to know that the organization presenting itself as their independent advocate is controlled by their largest corporate competitor in the market.

Within the VGP member portal, VitalRads is a listed preferred partner with a "Partner Benefits Summary" available to logged-in members. The specific discount terms are gated behind the login. But the structural reality is confirmed in VGP's own membership agreement, a public document on vgpvet.com. Section 1.4 of that agreement states explicitly: "Member acknowledges that it has been notified that some or all of the Providers will pay to VGP certain fees or rebates in connection with Member's purchases from such Providers. Member shall have no claim on those fees or rebates."

Read that again in context. The organization that presents itself to independent practices as their purchasing advocate — the one negotiating "best-in-class" deals on their behalf — discloses in its own membership contract that its vendor partners pay VGP fees or rebates when members purchase from them. VitalRads is a VGP vendor partner. VitalRads is owned by Thrive, which operates VGP. Every time a VGP member practice sends a case to VitalRads, a fee or rebate flows from VitalRads to VGP — which flows back to the same Thrive corporate balance sheet that owns both entities.

The 7,300 independent practices in the VGP network have not been acquired. They have not surrendered operational authority to Thrive. They are not contractually required to use VitalRads. But they have joined a membership organization under the premise of independent advocacy, encountered VitalRads as the featured teleradiology partner, and may have no idea that: the membership organization is run by the teleradiology company's corporate parent; that the "preferred pricing" they receive is set by that same corporate parent on a service it owns; that fees are flowing back to the corporate parent every time they use the service; and that genuine independent providers offering competitive pricing and superior quality exist but were never presented to them as options.

This is the VGP channel in economic terms: soft capture of 7,300 practices through information asymmetry. It is not a hard mandate. It is the architecture of default behavior — presenting VitalRads as the obvious, vetted, discounted choice within a trusted membership context, while concealing the ownership chain that makes "discount" a meaningless word. A price set by Thrive on a service owned by Thrive, marketed through a Thrive-operated network, is not a negotiated discount. It is a transfer payment from the practice to its own corporate competitor, dressed as a member benefit.

Channel Three: The Zoetis Portal Default

The third foreclosure channel operates through friction rather than mandate or financial incentive. A clinic that uses Zoetis as its diagnostic laboratory partner logs into ZoetisDx to access results. VitalRads teleradiology is embedded in the same portal, accessible through the same login, under the banner of "our VitalRADS service." The Zoetis teleradiology information sheet instructs clinics to "Sign in at ZoetisDx.com to see all the Virtual Laboratory has to offer." Signing up for VitalRads through ZoetisDx requires logging into the portal, navigating to the Consultations tab, and clicking Explore — three steps within a platform the clinic already uses daily.

Submitting the same imaging case to Golden Hour, PetRad, Vets Choice, or any other independent provider requires: exiting the ZoetisDx environment entirely; establishing a separate account with the independent provider; configuring a new DICOM destination in the clinic's imaging software; and managing a second workflow with a second login and a second reporting interface. That is not a neutral choice architecture. It is a system engineered to make VitalRads the path of least resistance and every competitor the path of additional effort.

The market-distortion effect across all three channels is compounding. A Zoetis laboratory customer who is also a VGP member has VitalRads presented to them through two separate institutional channels simultaneously — the portal they use for bloodwork and the membership organization they believe is advocating for them — before they ever make a conscious provider selection. If that same practice is acquired by Thrive, the question of provider selection disappears entirely. The architecture works at each level independently, and the overlapping coverage means that a very large proportion of the relevant market has been subjected to at least one layer of VitalRads steering, and many practices have been subjected to multiple layers at once.

What This Costs Pet Owners

The harm in this structure ultimately falls on the animal patient and the person paying the bill. The veterinary teleradiology market in a genuinely competitive state prices routine board-certified radiograph reads between $75 and $125 per study from independent providers. That market discipline — the knowledge that a superior competitor is one click away — is what motivates providers to invest in quality, speed, and service. Remove that discipline through captive mandates, soft-capture membership channels, and portal-default architecture, and the pricing pressure that benefits pet owners evaporates.

The pet owner at a Thrive clinic pays whatever VitalRads charges — a price set by Thrive on a service it owns, with no competitive check on that price because the clinic has no ability to route to a lower-cost competitor. The pet owner at an independent VGP member clinic pays the VGP "member price" on VitalRads — a price set by the same Thrive corporate parent, dressed as a negotiated discount, with the fees flowing back to the entity that set the price. The pet owner at a Zoetis laboratory client clinic pays whatever VitalRads charges through the ZoetisDx portal — a price that benefits from the default position in a trusted workflow, with zero competitive transparency.

None of these pet owners see any of this. They see a line item on an invoice for "radiology interpretation." They have no visibility into the ownership chain behind that line item, the financial incentive structure that determined which radiologist read their animal's images, or the competitive market that could have served them better and more cheaply if their clinic had been free to choose.

The Legal Framework — Three Distinct Theories of Liability

The anticompetitive structure of the Thrive ecosystem generates exposure under three distinct legal frameworks, each reaching a different part of the architecture.

The first is vertical integration with foreclosure effects under Sherman Act Section 1 and Section 2. Where a firm with market power in one market — veterinary clinic ownership and management services — uses that power to foreclose competition in an adjacent market — veterinary teleradiology — through captive mandates and exclusive dealing arrangements, the conduct is actionable under the rule of reason. The captive-clinic channel is the clearest version of this: 380 clinic locations directed exclusively to a Thrive subsidiary, eliminating competition not on the merits but through corporate mandate. For analysis of how IDEXX and Mars/Antech have assembled comparable vertical architectures, see The Stack: How IDEXX Built a Vertical Monopoly and The Mars Empire. For the broader question of whether enforcement authorities have the tools to address these structures, see The Enforcement Gap.

The second is the undisclosed referral fee structure embedded in the VGP membership model. VGP's own membership agreement confirms that providers pay VGP fees or rebates when members purchase from them. Under state veterinary anti-kickback and fee-splitting statutes in California, Texas, Florida, New York, and Illinois — the professional conduct rules examined in depth in The AVMA Says It's Unethical. Multiple States Say It's Illegal. Nobody Is Enforcing Either — the undisclosed financial benefit flowing from VitalRads to VGP (and thereby to Thrive) in connection with steering member practices to VitalRads constitutes precisely the undisclosed referral consideration those statutes are designed to reach. The fact that VGP's contract nominally discloses that providers pay fees does not cure the defect: the disclosure does not name VitalRads specifically, does not disclose the ownership relationship between VGP and VitalRads, and does not give member practices meaningful information about the conflict of interest involved in being steered to a service owned by the organization advising them.

The third is FTC Section 5 unfair methods of competition. The complete architecture — captive mandates, soft-capture MSO channel with undisclosed ownership, portal-default integration, and the compounding coverage of all three across the same market — is a comprehensive system designed to make genuine competition structurally impossible for independent teleradiology providers. It does not rely on any single anticompetitive act. It relies on the cumulative, interlocking effect of every layer working in the same direction simultaneously. The FTC's authority under Section 5 reaches conduct of this kind where the aggregate market effect forecloses competition even if no single element would independently trigger per se antitrust liability.

What a Competitive Market Would Look Like — and Why It Matters

The practical test for whether a market is genuinely competitive is simple: can the best provider win? In the veterinary teleradiology market as it would function without captive mandates and soft-capture channels, a clinic would evaluate Golden Hour, PetRad, Vets Choice Radiology, VitalRads, and every other available provider based on report quality, turnaround time, board-certification credentials, availability, and price. The provider that delivered the best combination of those attributes for that clinic's patient population and workflow would earn the business. Superior quality would be rewarded. Below-market pricing would attract volume. Poor performance would cost cases. That is how competitive markets produce better outcomes for consumers — which in this case means more accurate diagnostic reports, faster treatment decisions, and lower costs passed through to pet owners.

The Thrive ecosystem, at every layer, substitutes commercial relationships for that competitive evaluation. A Thrive clinic veterinarian cannot choose based on quality because the choice has been made for them. A VGP member cannot compare providers accurately because the VGP platform presents one provider — the one that pays VGP fees and is owned by VGP's parent — as the featured option, without disclosing any of that to the member. A Zoetis diagnostic customer encounters VitalRads as the default before they have ever compared alternatives, because VitalRads' corporate parent arranged with Zoetis to make it so.

The result is a market in which a very large number of veterinary imaging cases are routed to a single corporate-owned service through mechanisms that have nothing to do with the service's clinical merit. Whether VitalRads produces excellent diagnostic reports is, in this architecture, largely irrelevant to whether it receives the cases. It receives the cases because the structure is designed to send them there. And independent providers that may be producing superior work at lower prices are systematically excluded — not by failing to compete, but by being positioned outside the channels through which clinical decisions are being made.

Pet owners cannot see any of this. They cannot evaluate it. They cannot correct for it. The single most important piece of consumer protection in this market — the ability of a veterinary practice to choose the best available specialist for a given patient's needs — has been systematically compromised across hundreds of thousands of annual diagnostic transactions. That is the harm. It is not abstract. It is the difference between a pet that gets an excellent, fast, independently chosen diagnostic read and a pet whose diagnostic routing was predetermined by a corporate financial architecture before the animal ever walked in the door.

The Residency Problem: Who Is Actually Reading Your Film?

VitalRads operates an ACVR-approved radiology residency program under the directorship of Brian Poteet. The program's approval has been continuous and is currently granted through December 31, 2027. This is genuine institutional recognition — not every commercial teleradiology practice can sustain an accredited training program, and the designation reflects real commitment to training standards and case volume.

But the residency operates inside a corporate structure with incentives that point in a specific direction. Residents — veterinarians still in training toward DACVR certification — read cases as part of their education. Their labor costs less than a fully credentialed diplomate's. A high-volume commercial operation carrying the financial pressures documented above has every structural reason to maximize the proportion of reads performed by residents under nominal supervision, rather than by fully credentialed specialists at full cost.

VitalRads' own marketing consistently emphasizes board-certified specialists. The Zoetis partnership page states explicitly that "all teleradiography cases are reviewed and finalized by board-certified specialists." ACVR standards require that resident reads be supervised — the supervising diplomate must review and take responsibility for the report. Whether that supervision is substantive across a high-volume production environment serving hundreds of captive Thrive clinic locations is a question the public record cannot answer. What it can establish is the incentive structure surrounding the question: a distressed-balance-sheet parent, a captive referral pipeline, and a training program whose trainees are cheaper than the credentialed specialists whose credentials are being marketed to the clinics paying for reads.

The Full Timeline: What the Record Actually Shows